An in-depth look to DAEHAN NEW PHARM CO., LTD. operating, investing, and financing activities

054670 free cash flow for Q3 24 is -4.44 B KRW. For 2023, 054670 free cash flow was 2.83 B KRW and operating cash flow was 12.57 B KRW.